| UniProt ID | DNJC5_HUMAN | |
|---|---|---|
| UniProt AC | Q9H3Z4 | |
| Protein Name | DnaJ homolog subfamily C member 5 {ECO:0000305} | |
| Gene Name | DNAJC5 {ECO:0000312|HGNC:HGNC:16235} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 198 | |
| Subcellular Localization |
Membrane Lipid-anchor . Melanosome . Cell membrane . Identified by mass spectrometry in melanosome fractions from stage I to stage IV. |
|
| Protein Description | Acts as a general chaperone in regulated exocytosis (By similarity). Acts as a co-chaperone for the SNARE protein SNAP-25 (By similarity). Involved in the calcium-mediated control of a late stage of exocytosis (By similarity). May have an important role in presynaptic function. May be involved in calcium-dependent neurotransmitter release at nerve endings (By similarity).. | |
| Protein Sequence | MADQRQRSLSTSGESLYHVLGLDKNATSDDIKKSYRKLALKYHPDKNPDNPEAADKFKEINNAHAILTDATKRNIYDKYGSLGLYVAEQFGEENVNTYFVLSSWWAKALFVFCGLLTCCYCCCCLCCCFNCCCGKCKPKAPEGEETEFYVSPEDLEAQLQSDEREATDTPIVIQPASATETTQLTADSHPSYHTDGFN | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 8 | Phosphorylation | MADQRQRSLSTSGES CCHHHHHHCCCCCCH | 20.52 | 29255136 | |
| 10 | Phosphorylation | DQRQRSLSTSGESLY HHHHHHCCCCCCHHH | 23.05 | 29255136 | |
| 11 | Phosphorylation | QRQRSLSTSGESLYH HHHHHCCCCCCHHHH | 46.15 | 29255136 | |
| 12 | Phosphorylation | RQRSLSTSGESLYHV HHHHCCCCCCHHHHH | 36.87 | 22167270 | |
| 15 | Phosphorylation | SLSTSGESLYHVLGL HCCCCCCHHHHHHCC | 37.44 | 22167270 | |
| 17 | Phosphorylation | STSGESLYHVLGLDK CCCCCHHHHHHCCCC | 10.12 | 22167270 | |
| 24 | Ubiquitination | YHVLGLDKNATSDDI HHHHCCCCCCCHHHH | 54.23 | - | |
| 27 | Phosphorylation | LGLDKNATSDDIKKS HCCCCCCCHHHHHHH | 41.92 | 23401153 | |
| 28 | Phosphorylation | GLDKNATSDDIKKSY CCCCCCCHHHHHHHH | 30.76 | 27080861 | |
| 34 | Phosphorylation | TSDDIKKSYRKLALK CHHHHHHHHHHHHHH | 25.76 | 23312004 | |
| 35 | Phosphorylation | SDDIKKSYRKLALKY HHHHHHHHHHHHHHH | 22.20 | 23312004 | |
| 41 | Acetylation | SYRKLALKYHPDKNP HHHHHHHHHCCCCCC | 35.59 | 7774243 | |
| 41 | Ubiquitination | SYRKLALKYHPDKNP HHHHHHHHHCCCCCC | 35.59 | 21890473 | |
| 41 (in isoform 1) | Ubiquitination | - | 35.59 | 21890473 | |
| 41 (in isoform 2) | Ubiquitination | - | 35.59 | 21890473 | |
| 42 | Phosphorylation | YRKLALKYHPDKNPD HHHHHHHHCCCCCCC | 21.31 | 28152594 | |
| 46 (in isoform 1) | Ubiquitination | - | 74.88 | 21890473 | |
| 46 (in isoform 2) | Ubiquitination | - | 74.88 | 21890473 | |
| 46 | Ubiquitination | ALKYHPDKNPDNPEA HHHHCCCCCCCCHHH | 74.88 | 21906983 | |
| 56 (in isoform 1) | Ubiquitination | - | 54.32 | 21890473 | |
| 56 (in isoform 2) | Ubiquitination | - | 54.32 | 21890473 | |
| 56 | Ubiquitination | DNPEAADKFKEINNA CCHHHHHHHHHHHHH | 54.32 | 21890473 | |
| 56 | Acetylation | DNPEAADKFKEINNA CCHHHHHHHHHHHHH | 54.32 | 19608861 | |
| 58 (in isoform 1) | Ubiquitination | - | 64.52 | 21890473 | |
| 58 | Ubiquitination | PEAADKFKEINNAHA HHHHHHHHHHHHHHH | 64.52 | 21890473 | |
| 58 (in isoform 2) | Ubiquitination | - | 64.52 | 21890473 | |
| 72 (in isoform 1) | Ubiquitination | - | 45.21 | 21890473 | |
| 72 | Ubiquitination | AILTDATKRNIYDKY HHCCHHHHCCHHHHH | 45.21 | 2190698 | |
| 72 | 2-Hydroxyisobutyrylation | AILTDATKRNIYDKY HHCCHHHHCCHHHHH | 45.21 | - | |
| 72 (in isoform 2) | Ubiquitination | - | 45.21 | 21890473 | |
| 113 | S-palmitoylation | AKALFVFCGLLTCCY HHHHHHHHHHHHHHH | 2.93 | 28127059 | |
| 118 | S-palmitoylation | VFCGLLTCCYCCCCL HHHHHHHHHHHHHHH | 1.25 | 28127059 | |
| 119 | S-palmitoylation | FCGLLTCCYCCCCLC HHHHHHHHHHHHHHH | 2.16 | 28127059 | |
| 121 | S-palmitoylation | GLLTCCYCCCCLCCC HHHHHHHHHHHHHHH | 0.62 | 28127059 | |
| 122 | S-palmitoylation | LLTCCYCCCCLCCCF HHHHHHHHHHHHHHH | 0.49 | 28127059 | |
| 123 | S-palmitoylation | LTCCYCCCCLCCCFN HHHHHHHHHHHHHHH | 1.45 | 28127059 | |
| 124 | S-palmitoylation | TCCYCCCCLCCCFNC HHHHHHHHHHHHHHH | 1.71 | 28127059 | |
| 126 | S-palmitoylation | CYCCCCLCCCFNCCC HHHHHHHHHHHHHHC | 0.88 | 28127059 | |
| 127 | S-palmitoylation | YCCCCLCCCFNCCCG HHHHHHHHHHHHHCC | 1.59 | 28127059 | |
| 128 | S-palmitoylation | CCCCLCCCFNCCCGK HHHHHHHHHHHHCCC | 2.40 | 28127059 | |
| 131 | S-palmitoylation | CLCCCFNCCCGKCKP HHHHHHHHHCCCCCC | 0.73 | 28127059 | |
| 132 | S-palmitoylation | LCCCFNCCCGKCKPK HHHHHHHHCCCCCCC | 3.44 | 28127059 | |
| 133 | S-palmitoylation | CCCFNCCCGKCKPKA HHHHHHHCCCCCCCC | 6.77 | 28127059 | |
| 136 | S-palmitoylation | FNCCCGKCKPKAPEG HHHHCCCCCCCCCCC | 5.75 | 28127059 | |
| 146 | Phosphorylation | KAPEGEETEFYVSPE CCCCCCCCEEEECHH | 27.39 | 29978859 | |
| 149 (in isoform 2) | Phosphorylation | - | 8.19 | 24173317 | |
| 149 | Phosphorylation | EGEETEFYVSPEDLE CCCCCEEEECHHHHH | 8.19 | 28796482 | |
| 151 | Phosphorylation | EETEFYVSPEDLEAQ CCCEEEECHHHHHHH | 15.93 | 28442448 | |
| 161 (in isoform 2) | Phosphorylation | - | 50.46 | 25849741 | |
| 161 | Phosphorylation | DLEAQLQSDEREATD HHHHHHHCCCCCCCC | 50.46 | 25849741 | |
| 167 | Phosphorylation | QSDEREATDTPIVIQ HCCCCCCCCCCEEEE | 35.34 | 25002506 | |
| 169 | Phosphorylation | DEREATDTPIVIQPA CCCCCCCCCEEEECC | 15.57 | 25002506 | |
| 177 | Phosphorylation | PIVIQPASATETTQL CEEEECCCCCCCEEC | 42.27 | 26471730 | |
| 179 | Phosphorylation | VIQPASATETTQLTA EEECCCCCCCEECCC | 31.22 | 24076635 | |
| 181 | Phosphorylation | QPASATETTQLTADS ECCCCCCCEECCCCC | 18.58 | 26471730 | |
| 182 | Phosphorylation | PASATETTQLTADSH CCCCCCCEECCCCCC | 18.49 | 29978859 | |
| 185 | Phosphorylation | ATETTQLTADSHPSY CCCCEECCCCCCCCC | 20.71 | 29978859 | |
| 188 | Phosphorylation | TTQLTADSHPSYHTD CEECCCCCCCCCCCC | 34.53 | 29978859 | |
| 191 | Phosphorylation | LTADSHPSYHTDGFN CCCCCCCCCCCCCCC | 24.91 | 29978859 | |
| 192 | Phosphorylation | TADSHPSYHTDGFN- CCCCCCCCCCCCCC- | 17.12 | 25884760 | |
| 194 | Phosphorylation | DSHPSYHTDGFN--- CCCCCCCCCCCC--- | 29.59 | 24719451 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DNJC5_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| CFTR_HUMAN | CFTR | physical | 12039948 | |
| CHIP_HUMAN | STUB1 | physical | 19098309 | |
| HSP74_HUMAN | HSPA4 | physical | 19098309 | |
| VINC_HUMAN | VCL | physical | 22939629 | |
| ECE1_HUMAN | ECE1 | physical | 22939629 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 162350 | Ceroid lipofuscinosis, neuronal, 4B (CLN4B) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-41 AND LYS-56, AND MASSSPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10 AND SER-15, AND MASSSPECTROMETRY. | |
| "Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10, AND MASSSPECTROMETRY. | |
| "Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10, AND MASSSPECTROMETRY. | |
| "Global phosphoproteome of HT-29 human colon adenocarcinoma cells."; Kim J.-E., Tannenbaum S.R., White F.M.; J. Proteome Res. 4:1339-1346(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10, AND MASSSPECTROMETRY. | |
| "Identification and characterization of phosphorylated proteins in thehuman pituitary."; Giorgianni F., Beranova-Giorgianni S., Desiderio D.M.; Proteomics 4:587-598(2004). Cited for: PHOSPHORYLATION AT SER-10. | |